Does Plant Sterols Triglycerides Meta-Analysis work?

The current Migaku evidence database contains 2 reusable source documents for Plant Sterols Triglycerides Meta-Analysis. This answer focuses on strength of evidence and what the studies can or cannot prove. - Dyslipidemias, particularly those associated with an increase in the circulating burden of atherogenic apolipoprotein (Apo) B-containing lipoproteins, such as hypercholesterolemia (elevated total cholesterol and low-density lipoprotein cholesterol [LDL-C]), hypertriglyceridemia (elevated triglycerides [TG]), and mixed dyslipidemia (elevated LDL-C and TG), are well-established ASCVD risk factors [,,]. [Maki Kevin C. (2026); evidence level 3] - LDL-C and non-high-density lipoprotein cholesterol (non-HDL-C), which is calculated as the concentration of total cholesterol minus the concentration of high-density lipoprotein cholesterol (HDL-C) and is a comprehensive measurement of cholesterol carried by all Apo B-containing lipoproteins, are the targets for therapies to lower ASCVD risk []. [Maki Kevin C. (2026); evidence level 3] - Changes in both have been shown to predict changes in risk, and these relationships are believed to reflect a causal association of the burden of atherogenic lipoprotein particles with the initiation and progression of ASCVD. [Maki Kevin C. (2026); evidence level 3] - 1 1 2 3 4 5 6 Atherosclerotic cardiovascular disease (ASCVD) is one of the leading causes of death worldwide []. [Maki Kevin C. (2026); evidence level 3] - This shift reflects the broader understanding that residual cardiovascular risk persists even after LDL-lowering, due to persistent vascular inflammation, metabolic dysfunction, and non-lipid contributors to plaque progression. [Kovyanova Tatyana I. (2026); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.